BC

Bail Capital

North America, California, United States, Santa Monica

Description

Bail Capital is an investment Firm.

Investor Profile

Bail Capital has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (40%)
  • Series A (40%)
  • Series Unknown (20%)

Country Focus

  • United States (40%)
  • Germany (20%)
  • United Kingdom (20%)
  • Canada (20%)

Industry Focus

  • Health Care
  • Biotechnology
  • Life Science
  • Mental Health
  • Medical
  • Therapeutics
  • Clinical Trials
  • Email
  • Personal Development
  • Psychology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bail Capital frequently co-invest with?

Infinitas Capital
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Bracket Capital
North America, California, United States, West Hollywood
Co-Investments: 1
Subversive Capital
North America, New York, United States, New York
Co-Investments: 2
BD
North America, California, United States, San Francisco
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Noetic Fund
North America, Ontario, Canada, Toronto
Co-Investments: 3
Redbus Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Able Partners
North America, New York, United States, New York
Co-Investments: 1
Recharge Capital
North America, New York, United States, New York
Co-Investments: 1
Apeiron Investment Group
Europe, NA - Malta, Malta, Sliema
Co-Investments: 1

Which angels does Bail Capital often collaborate with?

RR
Europe, England, United Kingdom, London
Shared Deals: 1
MM
North America, California, United States, San Francisco
Shared Deals: 1
EK
North America, New York, United States, New York
Shared Deals: 1
JM
Europe, Islas Baleares, Spain, San José
Shared Deals: 1

What are some of recent deals done by Bail Capital?

Lykos Therapeutics

San Jose, California, United States

Lykos Therapeutics catalyzes healing and well-being through psychedelic drug development, therapist training programs.

Clinical TrialsEmailHealth CareMedicalPersonal DevelopmentPsychology
Series AJan 5, 2024
Amount Raised: $100,000,000
Delix Therapeutics

Boston, Massachusetts, United States

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

BiotechnologyHealth CareLife Science
Series ASep 27, 2021
Amount Raised: $70,000,000
Beckley Psytech

Beckley, Oxfordshire, United Kingdom

Beckley Psytech is a clinical-stage biotechnology company that explores the therapeutic potential of psychedelic substances.

BiotechnologyHealth CareMedical
Series UnknownDec 23, 2020
Amount Raised: $18,918,101
Cybin

Toronto, Ontario, Canada

Cybin is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

BiotechnologyHealth CareMental HealthPharmaceutical
Series BJul 1, 2020
Amount Raised: $33,104,739
ATAI Life Sciences

Munich, Bayern, Germany

ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.

BiotechnologyHealth CareLife ScienceMental HealthTherapeutics
Series BMar 1, 2019
Amount Raised: $43,000,000